The cost impact of cytomegalovirus disease in renal transplant recipients.
A retrospective case controlled study was performed to determine the cost impact of cytomegalovirus disease in the first year following renal transplantation as a basis for the analysis of cost effectiveness of prophylactic and therapeutic regimens directed at CMV infection.
Eleven sequential cases of organ-specific CMV disease were matched with 22 controls for age, diabetic status, and donor/recipient CMV serologic status from 119 consecutive first cadaveric renal transplant recipients performed at a single university-affiliated, solid organ transplant unit between January 1, 1988 and March 31, 1990.
The groups were comparable for sex, HLA match and mismatch, incidence of initial graft dysfunction, and immunosuppression.
Mots-clés Pascal : Virose, Infection, Cytomegalovirus, Betaherpesvirinae, Herpesviridae, Virus, Postopératoire, Chirurgie, Transplantation, Homotransplantation, Appareil urinaire pathologie, Rein, Homme, Aspect économique, Etude impact, Economie santé, Canada, Amérique du Nord, Amérique, Etude cas témoin
Mots-clés Pascal anglais : Viral disease, Infection, Cytomegalovirus, Betaherpesvirinae, Herpesviridae, Virus, Postoperative, Surgery, Transplantation, Homotransplantation, Urinary system disease, Kidney, Human, Economic aspect, Impact study, Health economy, Canada, North America, America, Case control study
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0573921
Code Inist : 002B30A03B. Création : 199406.